Navigation Links
Progen in Medical News

Progen Receives Nasdaq Notice Regarding Board Composition

...ISBANE, Calif., April 22 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA ...n during the 27th of March 2009 General Meeting of progen shareholders, as reported by the Company at the ti... fiscal year, which ends on the 30th of June 2009, progen intends to expand the board with independent direc...

Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth

...epigenetics research and cancer therapeutics. progen CEO Justus Homburg said the latest findings reinfo...r silencing (switching off) of certain genes. progen and its collaborators have focused their research ...ns." In addition to its epigenetics findings, progen also presented an update on its cell proliferation...

Progen Investor Teleconference Dial In Details

...e contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of ...

Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer

... the assessment of delaying tumour recurrence following curative resection, progen is confident that its Phase 3 trial meets the FDA requirements for approval...and regulatory submissions have been filed in key countries. About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnolo...

Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases

...vival. These results, combined with positive feedback from the FDA, provide progen with confidence in the potential of PI-88 for this indication and we are th... its development towards registration and commercialization. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnolog...

US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer

... BRISBANE, Sept. 24 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) a...dical need. The Fast Track designation will enable progen to file a New Drug Application (NDA) on a rolling ...n, in more than a dozen countries. About Progen: progen Pharmaceuticals Limited is an Australian-based glo...
Progen in Medical Technology

Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A

...continued the PI-88 phase 3 study in liver cancer. progen confirmed its strategic direction to develop its e...the phase 3 PATHWAY trial. The next step is that progen will seek expressions of interest in PI-88, at a r...ess than $4.0m. As part of the strategic review, progen has determined that the current phase 2b melanoma ...

Presentation of Data on Progen's Cancer Epigenetic Targets Platform

...g this novel therapeutic area", said Dr. Marton. progen already has preliminary preclinical efficacy data ...ranslational epigenetics research. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has built a focus and strength in anti-cancer drug...

Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047

...ly CGC-11047) for patients with advanced cancer. progen has commenced development of PG-11047 - the lead c...ce data within the next 12 months. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. About PG...

PG500 Series Presented at the AACR Annual Meeting in San Diego

...this calendar year, or early 2009. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. About the PG500 series: progen has an innovative small molecule Drug Discovery te...

Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer

...d Drug Administration (FDA). These results provide progen with confidence in the potential of PI-88 for this...obal regulatory filings for PI-88. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. ...

Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium

...nia in this phase 3 study, as it is a monotherapy study in a patient population with which we already have substantial clinical data." About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialization of...

Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer

...or registration strategy. At this point in time, progen has received regulatory approval to conduct the ph...d Drug Administration (FDA). These results provide progen with confidence in the potential of PI-88 for this...obal regulatory filings for PI-88. About Progen: progen Pharmaceuticals Limited is an Australia-based glob...

Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases

...vival. These results, combined with positive feedback from the FDA, provide progen with confidence in the potential of PI-88 for this indication and we are th... its development towards registration and commercialization. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnolog...

Progen Announces PI-88 Phase 2 Lung Cancer Results

... BRISBANE, Sept. 24 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) t...n the primary liver cancer trial." About Progen: progen Pharmaceuticals Limited is an Australian-based glo...erapeutics primarily for the treatment of cancer. progen Information: Justus Homburg ...

Progen Pharmaceuticals Announces Fiscal 2007 Financial Results

...gh various fundraising activities, which provides progen with additional working capital to fund the Phase...Alliance between the two companies, which provides progen with maximum flexibility and the opportunity to m... American Association of Cancer Research meeting. progen expects to submit an Investigational New Drug app...
Progen in Biological Technology

Cytopia Letter to Progen Shareholders

MELBOURNE, Australia, Feb. 25 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has today circulated a letter and other materials to Progen Pharmaceuticals Limited (ASX: PGL) shareholders. The letter provides an update on the current shareholders requisitioned meeting scheduled for 27 March 2009 and prov...

Cytopia and Other Progen Shareholders Maintain Call for Meeting

MELBOURNE, Australia, Feb. 9 /PRNewswire/ -- Shareholders continue to support choice of cash back option and new Progen board Call by over 18% of Progen shareholders to combine general meetings Significant funding shortfall identified in the Progen merger proposa...

Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders

MELBOURNE, Australia, Jan. 28 /PRNewswire/ -- Cytopia Ltd (ASX: CYT) has joined with other Progen Pharmaceuticals Ltd (ASX: PGL) shareholders to call a Progen general meeting to elect a new board, pursue a merger and enable the first full share buyback offer to Progen shareholders. Key resolu...

Progen Concedes Shareholder Requisitioned Meeting

... -- progen board; - finally accepts legitimate ca... 19 /PRNewswire-FirstCall/ -- A general meeting of progen Pharmaceuticals Ltd (ASX:PGL) shareholders was val...ary 28, 2009 by Cytopia Ltd (ASX:CYT) and 14 other progen shareholders. The resolutions sought to achieve tw...

Progen Restructures Manufacturing and Drug Discovery Divisions

... and the manufacture of drug development material. progen expects the transfer of PI-88 manufacture to occur in the next 12 to 18 months. progen will maintain the manufacturing facility with exis...rrent cash reserves for driving present and future progen lead compounds towards commercialization. In...

Progen Expands Board of Directors

... These additions and changes strengthen and focus the Board's expertise as progen embarks on its next stage of growth with the continued development and comm...the growth of its scientific and consulting business, and has served on the progen Board as non-executive director since 1999, prior to his most recent appoin...

Progen Expands Drug Development Pipeline Through Acquisition of CellGate

... compounds. As a result of this acquisition, progen will: -- expand its cancer-focused clinical deve... is becoming a well-defined target in oncology and progen is excited to be entering this new frontier of can...esents a minimally dilutive up-front investment by progen and allows us to continue expanding our product pi...

Progen Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference

... accessed on the Company's website at http://www.progen-pharma.com . A replay of the webcast will be available for 30 days thereafter. About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialisation of...
Other Tags
(Date:9/19/2014)... human cancers have abnormally upregulated chemical signals related ... controlled during tumor formation is not fully understood. ... PhD, both researchers in the department of Pathology ... Medicine, University of Pennsylvania, and colleagues report that ... by targeting these pathways. , Lipid second messengers ...
(Date:9/19/2014)... Hastings and Hastings, a discount accident lawyer in Phoenix, Arizona, ... number of visitors to its new Phoenix personal injury website. ... as well as auto accident cases and slip & fall ... others. Having served the state of Arizona for over 30 ... when it comes to dedicated and focused personal injury legal ...
(Date:9/19/2014)... Dartmouth researcher, working with The Melanoma Genetics Consortium, GenoMEL, ... in the Journal of the National Cancer Institute ... melanoma. , "For the first time, we have established ... play a part in the risk of developing melanoma," ... School of Medicine at the University of Leeds (UK). ...
(Date:9/19/2014)... Visiting Nurse Association (VNA) Health Group, ... hospice and palliative care and community-based care, was honored ... yesterday at the New York Stock Exchange. , Founded ... entrepreneur to care for immigrant families suffering from tuberculosis ... to meet the urgent healthcare needs of the communities ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 According to ... of the embattled blood-thinner Xarelto, named as defendants in ... Common Pleas, have moved the court to dismiss those ... not have sufficient connection with Philadelphia.* The cases include, ... al. (No. 140304328; Pa. Comm. Pls., Philadelphia Cty.), which ...
Breaking Medicine News(10 mins):Health News:New cancer drug target involving lipid chemical messengers 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Melanoma risk found to have genetic determinant 2Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 2Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 3Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3
(Date:9/18/2014)... the fish world, are the ideal animal in which ... moved from the ocean into tens of thousands of ... changing their skeleton to adapt to the new environment. ... sticklebacks now have turned up one of the genes ... change in that gene,s regulation in a freshwater population ...
(Date:9/18/2014)... has found clownfish larvae can swim up to 400 kilometres ... to cope with environmental change. , Clownfish spend their entire ... as babies they must wander the open ocean, says study ... for Coral Reef Studies (Coral CoE) at James Cook University. ... but now we,ve been given a rare glimpse into how ...
(Date:9/17/2014)... From accessible and affordable health care to reproductive ... depend on the ability of people to identify ... openly and respectfully, and find the most defensible ... practices to support these societal conversations?, The Hastings ... of Bioethical Issues have teamed up to publish ...
Breaking Biology News(10 mins):Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Nemo's epic journey to find a new home 2Why bioethics literacy matters 2Why bioethics literacy matters 3
Other Contents